Review



luc b16f10 cells  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Novus Biologicals luc b16f10 cells
    Luc B16f10 Cells, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/Exosome+Standards+(B16F10+cell+line)/pm40570715-199-6-16
    Average 93 stars, based on 1 article reviews
    luc b16f10 cells - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Staining:

    Article Title: Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy.
    Article Snippet: Tumor cells from tumor tissues and blood were obtained for PD-L1 and Gal-9 disruption detections processed by Cleavage Detection Kit (Invitrogen, Cat no. A24372).

    Luciferase:

    Article Title: Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy.
    Article Snippet: Tumor cells from tumor tissues and blood were obtained for PD-L1 and Gal-9 disruption detections processed by Cleavage Detection Kit (Invitrogen, Cat no. A24372).

    FACS:

    Article Title: Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy.
    Article Snippet: Tumor cells from tumor tissues and blood were obtained for PD-L1 and Gal-9 disruption detections processed by Cleavage Detection Kit (Invitrogen, Cat no. A24372).



    Similar Products

    94
    ATCC b16f10 luc cells
    B16f10 Luc Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/B16-F10-Luc2/pmc12796310-488-6-10
    Average 94 stars, based on 1 article reviews
    b16f10 luc cells - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    ATCC t cellswere coculturedwith b16f10 luc cells
    T Cellswere Coculturedwith B16f10 Luc Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/B16-F10-Luc2/pm41526341-491-1-8
    Average 94 stars, based on 1 article reviews
    t cellswere coculturedwith b16f10 luc cells - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    99
    ATCC b16f10 b16f10 luc cells
    ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with <t>B16F10-luc</t> cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    B16f10 B16f10 Luc Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/B16-F10/pmc12646671-215-1-16
    Average 99 stars, based on 1 article reviews
    b16f10 b16f10 luc cells - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC 480 luciferase overexpressed b16f10 b16f10 luc cells
    ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with <t>B16F10-luc</t> cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    480 Luciferase Overexpressed B16f10 B16f10 Luc Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/B16-F10/10__1172_slash_jci190958-229-0-19
    Average 99 stars, based on 1 article reviews
    480 luciferase overexpressed b16f10 b16f10 luc cells - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    93
    Novus Biologicals luc b16f10 cells
    ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with <t>B16F10-luc</t> cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Luc B16f10 Cells, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/Exosome+Standards+(B16F10+cell+line)/pm40570715-199-6-16
    Average 93 stars, based on 1 article reviews
    luc b16f10 cells - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    99
    ATCC b16f10 cell line expressing luciferase b16f10 luc
    ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with <t>B16F10-luc</t> cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    B16f10 Cell Line Expressing Luciferase B16f10 Luc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/B16-F10/pmc12084569-364-1-21
    Average 99 stars, based on 1 article reviews
    b16f10 cell line expressing luciferase b16f10 luc - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC b16f10 b16f10 luc melanoma cell lines
    ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with <t>B16F10-luc</t> cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    B16f10 B16f10 Luc Melanoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/B16-F10/pm39737211-263-3-12
    Average 99 stars, based on 1 article reviews
    b16f10 b16f10 luc melanoma cell lines - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    90
    Imanis Life Sciences LLC murine b16f10 (gp100þ) cells expressing gfp-firefly luciferase (gfp/luc)
    ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with <t>B16F10-luc</t> cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Murine B16f10 (Gp100þ) Cells Expressing Gfp Firefly Luciferase (Gfp/Luc), supplied by Imanis Life Sciences LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/b16f10+fluc+puro/10__1158_slash_2326___6066__cir___22___0978-68-0-11
    Average 90 stars, based on 1 article reviews
    murine b16f10 (gp100þ) cells expressing gfp-firefly luciferase (gfp/luc) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    99
    ATCC research cell line source s b16f10 expressing luciferase
    ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with <t>B16F10-luc</t> cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
    Research Cell Line Source S B16f10 Expressing Luciferase, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc+b16f10+cells/B16-F10/pm37640787-85-358-365
    Average 99 stars, based on 1 article reviews
    research cell line source s b16f10 expressing luciferase - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with B16F10-luc cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Journal: The Journal of Clinical Investigation

    Article Title: ER stress sensor PERK promotes T cell pathogenicity in GVHD by regulating ER-associated degradation

    doi: 10.1172/JCI190958

    Figure Lengend Snippet: ( A and B ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with allogeneic APCs from BDF1 mice for 4 days; levels of proinflammatory cytokines (IFN-γ, TNF-α) in CD8 + T cells were analyzed by flow cytometry ( A ). Percentages of CFSE lo IFN-γ + CD8 + and CFSE lo TNF-α + CD8 + T cells among gated H2K d– CD8 + T cells are shown ( B ). ( C and D ) CD8 + T cells isolated from 2C transgenic WT or PERK-cKO mice were labeled with CFSE and stimulated with SIY peptides (10 nM) and syngeneic B6 APCs (Ly5.1); levels of cytokines were analyzed similarly. ( E – G ) Lethally irradiated BDF1 mice (1,200 cGy) received TCD-BM cells (5 × 10 6 ) alone or along with P815-luc cells (5,000) with or without CD25-removed T cells (3 × 10 6 ) from 2C WT or PERK-cKO donors. Body weight loss ( E ) and GVHD scores ( F ) were monitored after BMT. Tumor growth in BDF1 recipients was monitored via BLI ( G ); n = 5 per BMT group. ( H ) CD8 + T cells from pMEL WT or PERK-cKO mice were stimulated with gp100 peptides and B6 APCs (Ly5.1) for 3 days; levels of IFN-γ and IL-17 in CD8 + T cells were analyzed. Percentages of IFN-γ + CD8 + and IL-17 + CD8 + T cells among gated CD45.1 – CD8 + T cells are shown. ( I and J ) Lethally irradiated BDF1 mice received TCD-BM cells (5 × 10 6 ) along with B16F10-luc cells with or without CD25-removed T cells (3 × 10 6 ) from pMEL WT or PERK-cKO donors; n = 3 for tumor only, n = 5–6 for WT or PERK-cKO ( I ). Survival ( J ) was monitored after BMT. Log-rank (Mantel-Cox) test ( J ) and non-parametric Mann-Whitney U test ( E and F ) were used to compare groups. Data in B , D , and H are represented as mean ± SD with biological replicates; significance was determined using a 2-tailed unpaired Student’s t test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Article Snippet: Luciferase-overexpressing B16F10 (B16F10-luc) cells were purchased from IVIS Imaging Co. Jurkat E6.1 cells were purchased from ATCC.

    Techniques: Isolation, Transgenic Assay, Labeling, Flow Cytometry, Irradiation, MANN-WHITNEY